Published in
American Chemical Society, Journal of Medicinal Chemistry, 22(63), p. 13595-13617, 2020
DOI: 10.1021/acs.jmedchem.0c00620
Links
Tools
4-(Difluoromethyl)-5-(4-((3R,5S)-3,5-dimethylmorpholino)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders
Journal article published in 2020 by
Chiara Borsari 
,
Erhan Keles,
Denise Rageot,
Andrea Treyer ,
Thomas Bohnacker,
Lukas Bissegger,
Martina De Pascale ,
Anna Melone,
Rohitha Sriramaratnam,
Florent Beaufils,
Matthias Hamburger ,
Paul Hebeisen,
Wolfgang Löscher,
Doriano Fabbro,
Petra Hillmann
and other authors.
,
Erhan Keles,
Denise Rageot,
Andrea Treyer ,
Thomas Bohnacker,
Lukas Bissegger,
Martina De Pascale ,
Anna Melone,
Rohitha Sriramaratnam,
Florent Beaufils,
Matthias Hamburger ,
Paul Hebeisen,
Wolfgang Löscher,
Doriano Fabbro,
Petra Hillmann
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 